BRIEFING MATERIALS FOR TOPIC 1
The following briefing materials are provided for Topic 1 of the October 25 & 26 meeting of the TSE Advisory Committee:
Foster, P.R., Prions and Blood Products. Ann. Med. 2000; 32:501-513
- US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeld-Jakob Disease (CJD) and Variant Creutzfeld-Jakob Disease (vCJD) by Blood and Blood Products, DRAFT GUIDANCE, August 2001.
- Summary and Rationale for this Draft Guidance
- USDA Letter dated October 5, 2001 to U.S. Importers, Brokers, and Other Interested Parties; Subject: Clarification of the Prohibition of the Importation of all Ruminant Meat, Meat Products and Other Ruminant Protein Products from Japan due to Bovine Spongiform Encephalopathy (BSE).
Lee, D.C., et. al. A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins, Transfusion, 2001; 41:499-455.